by Wyn Staheli, Director of Content - innoviHealth
Aug 31st, 2018
In January, the U.S. Department of Health and Human Services (HHS) issued updates to the privacy regulations regarding the confidentiality of patient information of substance use disorder patients (42 CFR Part 2). This notice included references to better alignment with HIPAA regulations, but did state that Part 2 is more protective in order to retain "important privacy protections for individuals seeking treatment for substance use disorders."
With the increase focus on integrated health care models as a pathway to better outcomes, these regulations are necessary to ensure the success of these programs.
The following sections were revised:
- 2.32 Prohibition on re-disclosure
- 2.33 Disclosures permitted with written consent
- 2.35 Disclosure to elements of the criminal justice system which have referred patients
- 2.53 Audit and evaluation
For detailed information, see the Federal Register notice beginning on page 47 (see References).
About Wyn Staheli, Director of Content - innoviHealth
Wyn Staheli is the Director of Content Research for innovHealth. She has over 30 years of experience in the healthcare industry. With her degree in Management Information Systems (MIS), she has been a programmer for a large insurance carrier as well as a California hospital system. She is also the author and editor of many medical resource books and the founder of InstaCode Institute.